OTC Medicines

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

CHPA is set to testify on Monday before the Massachusetts Joint Committee on Public Health. The hearing, which will be held virtually, is the first policy committee hearing for the Commonwealth’s legislature in 2021. Nearly 50 bills are scheduled to be considered during the hearing, including four bills on which CHPA will be testifying.

On Tuesday, April 13, the Oregon House Committee on Health Care voted unanimously to advance H.B. 2648 to the full House of Representatives for a vote.

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details. Federal Register notices are for general information purposes only and should not be relied upon as a substitute for thorough regulatory assessment. All efforts are made to assure the accuracy and completeness of this information, but CHPA cannot guarantee the information. As a benefit of CHPA membership, recipients are asked not to forward or share this information outside of your company.

This week, the House Energy and Commerce Health Subcommittee is holding a hearing, entitled: "An Epidemic within a Pandemic: Understanding Substance Use and Misuse in America."

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

On Wednesday, March 17, Mississippi Governor Tate Reeves signed S.B. 2119, repealing a law that overturns the state’s ban of over-the-counter (OTC) sales of pseudoephedrine (PSE).